Highly accurate identification of cystic precursor lesions of pancreatic cancer through targeted mass spectrometry: A phase IIc diagnostic study
Journal of Clinical Oncology Feb 13, 2018
Jabbar KS, et al. - The currently available diagnostic methods cannot accurated distinguish between premalignant and malignant pancreatic cystic lesions. In the current study it was demonstrated that highly accurate identification and assessment of cystic precursors to pancreatic adenocarcinoma was achieved by targeted mass spectrometry analysis of three cyst fluid biomarkers.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries